Volume Response to a Bronchodilator in Patients with COPD
Jimena Falco, Vanina Martín, Leandro Marozzi, Marco Antonio Solis Aramayo, Marcos Hernández, Edgardo M. Sobrino, Sílvia Quadrelli
Abstract
Jimena Falco, Vanina Martín, Leandro Marozzi, Marco Antonio Solis Aramayo, Marcos Hernández, Edgardo M. Sobrino, Sílvia Quadrelli
Abstract
"The chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation. It is a frequent, known and treatable disease. The diagnosis requires tobacco smoking personal history or expositional history and evidence of an obstructive pattern at the spirometry measured before and after bronchodilators. The degree of reversibility of airflow differs between patients, and does not predict the response to bronchodilator therapy. It can be seen in terms of forced vital capacity or forced expiratory flow, depending on the severity of the disease. This paper presents the differences in bronchodilator response in terms of measurements of the flow and the volume in patients diagnosed with COPD at different stages of GOLD. The bronchodilator response and its relationship to the severity of the disease were analized."
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
"The chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation. It is a frequent, known and treatable disease. The diagnosis requires tobacco smoking personal history or expositional history and evidence of an obstructive pattern at the spirometry measured before and after bronchodilators. The degree of reversibility of airflow differs between patients, and does not predict the response to bronchodilator therapy. It can be seen in terms of forced vital capacity or forced expiratory flow, depending on the severity of the disease. This paper presents the differences in bronchodilator response in terms of measurements of the flow and the volume in patients diagnosed with COPD at different stages of GOLD. The bronchodilator response and its relationship to the severity of the disease were analized."
Key concepts: Bronchodilator, COPD, Medicine, Spirometry, Bronchodilator Agents, Vital capacity, Pulmonary disease, Cardiology